Market Highlights
Cell counting market is expected to witness positive growth in future as it has wide range of applications in research institutes, hospitals, biotechnology and pharmaceuticals companies and it an important tool in research, drug discovery and biopharmaceutical applications. Increasing prevalence of cancer and rising geriatric population are major driver for the market growth. Furthermore, factors responsible for the growth of the cell counting market in Asia Pacific are rising awareness regarding prevalence of disease such as cancer and other lifestyle diseases and improvement in healthcare facilities. High cost of cell counting instruments may create an obstacle for the market growth.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/628
Asia Pacific cell counting market is expected to grow at a CAGR of 10.5% during forecast period 2017 to 2023.
Asia-Pacific Cell Counting Market Players:
Key players in cell counting market are Bio-Rad Laboratories Inc. (U.S), General Electric Company (U.S), Agilent Technologies (U.S), PerkinElmer Inc. (U.S), Tecan Trading AG (Switzerland), BioTek Instruments, Inc. (U.S), Danaher (U.S), Merck KGaA (U.S).
Segmentation:
The Asia Pacific cell counting market is segmented on the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments. On the basis of application of cell counting which includes cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications. It is also segmented on the basis of its end users which are hospitals, research institutes, pharmaceutical and biotechnology companies, clinical research organizations and other end users.
Regional Analysis:
Asia Pacific cell counting market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia Pacific. Japan is the largest market for cell counting due to an increase in prevalence of cancer and demand for new cell counting techniques.
China and Japan are major manufacturers of medical devices. In China, factors responsible for the market growth are rising geriatric population with chronic diseases, increasing experimental use of cell counting devices, and availability of low cost diagnostic and treatment options.
Rising number of diagnostic centers, growing emphasis of cell counting for the diagnosis of chronic diseases and overall growth of diagnostic services drive the market in India. Lack of awareness about the available diagnostic services also boost the market growth.
Australia and Republic of Korea show slow growth in cell counting market.
Access Report Details @
https://www.marketresearchfuture.com/reports/asia-pacific-cell-counting-market-628
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Market HighlightsCell counting market is expected to witness positive growth in future as it has wide range of applications in research institutes, hospitals, biotechnology and pharmaceuticals companies and it an important tool in research, drug discovery and biopharmaceutical applications.
Increasing prevalence of cancer and rising geriatric population are major driver for the market growth.
Furthermore, factors responsible for the growth of the cell counting market in Asia Pacific are rising awareness regarding prevalence of disease such as cancer and other lifestyle diseases and improvement in healthcare facilities.
Request Sample Copy:https://www.marketresearchfuture.com/sample_request/628Asia Pacific cell counting market is expected to grow at a CAGR of 10.5% during forecast period 2017 to 2023.Asia-Pacific Cell Counting Market Players:Key players in cell counting market are Bio-Rad Laboratories Inc. (U.S), General Electric Company (U.S), Agilent Technologies (U.S), PerkinElmer Inc. (U.S), Tecan Trading AG (Switzerland), BioTek Instruments, Inc. (U.S), Danaher (U.S), Merck KGaA (U.S).Segmentation:The Asia Pacific cell counting market is segmented on the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments.
On the basis of application of cell counting which includes cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications.
It is also segmented on the basis of its end users which are hospitals, research institutes, pharmaceutical and biotechnology companies, clinical research organizations and other end users.Regional Analysis:Asia Pacific cell counting market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia Pacific.
The global cell counting market is projected to reach USD 14.5 billion in 2025 from USD 10.4 billion in 2020, at a CAGR of 6.7 % during the forecast period.Cell Counting Market growth is largely driven by factors such as growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers.On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.By application, the research application segment accounted for the largest share of the cell counting market On the basis of application, the cell counting market is segmented into research, medical, and industrial applications.
In 2019, research applications accounted for the largest share of the market.
Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728By end user, the research institutes segment accounted for the largest share of the cell counting market On the basis of end users, the cell counting market is segmented into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and CROs, and other end users.
In 2019, research institutes accounted for the largest share of the market.
The large share of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R expenditure, and commercial expansion of various pharmaceutical companies.By region, North America accounted for the largest share of the cell counting market In 2019, North America accounted for the largest share of the cell counting consumables market, followed by Europe.
The large share of the North American market can be attributed to the increasing demand for technologically advanced instruments in research and diagnostic applications and the high prevalence of target conditions, coupled with the increasing demand for early and effective disease diagnosis and treatment.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728Leading Players The major companies in the cell counting market include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US)
